First cardiological or cardiosurgical reintervention for ischemic heart disease after primary coronary artery bypass

P Sergeant1, E Blackstone, B Meyns

  • 1Cardiac Surgery Department, Gasthuisberg University Hospital, Katholieke Universiteit, Leuven, Belgium. paul.sergeant@uz.kuleuven.ac.be

Insights

Reinterventions for ischemic heart disease after coronary artery bypass grafting (CABG) are infrequent early on but common later. Factors like age and graft type influence reintervention needs, with survival post-procedure varying.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Ischemic Heart Disease Research

Background:

  • Coronary artery bypass grafting (CABG) is a primary treatment for ischemic heart disease.
  • Understanding long-term reintervention rates and influencing factors post-CABG is crucial for patient management.

Purpose of the Study:

  • To investigate the incidence of first reintervention for ischemic heart disease after CABG.
  • To identify patient and procedural variables associated with the need for or bias in reintervention occurrence.

Main Methods:

  • Analysis of a consecutive series of 9600 CABG patients with up to 20 years of follow-up.
  • Multivariable time-related analysis to assess freedom from reintervention and survival.

Main Results:

  • 1-, 10-, and 15-year freedom from reintervention rates were 99%, 89%, and 72%, respectively.
  • Early reintervention was influenced by anginal instability and revascularization completeness; late reintervention by demographics, comorbidity, and arterial grafting.
  • 1-month and 10-year survival post-reintervention were 95% and 73%.

Conclusions:

  • Reinterventions are infrequent in the first decade post-CABG but common in the second.
  • Increased reintervention rates after 1985 did not correlate with improved late survival.
  • Older age and multiple arterial grafts may influence reintervention, suggesting a need for tailored therapeutic approaches.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...